Frastim 300 Mg Injection
300 INR/Piece
Product Details:
- Indication To reduce the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing chemotherapy for malignancy, and in patients undergoing bone marrow transplantation; also used to increase neutrophil counts in patients with severe chronic neutropenia.
- Salt Composition Filgrastim 300 mcg
- Dosage Form Injection
- Enzyme Types Colony Stimulating Factor (G-CSF, not a classic enzyme but a hematopoietic growth factor)
- Feature Sterile, preservative-free, ready-to-use prefilled syringe
- Ingredients Filgrastim, excipients (such as sorbitol, sodium acetate, polysorbate 80, water for injection)
- Application Used as an adjunct therapy for managing neutropenia in cancer patients, bone marrow disorders, and in peripheral blood progenitor cell collection.
- Click to View more
X
Frastim 300 Mg Injection Price And Quantity
- 1 Piece
- 300 INR/Piece
- Prescription only
- Should not be diluted with saline; only use 5% dextrose for dilution if necessary
- Known hypersensitivity to filgrastim or any component of the formulation
- 1 prefilled syringe of 1.0 ml
- Monitor for signs of splenic enlargement or rupture, allergic reaction, or adult respiratory distress syndrome
- Subcutaneous or intravenous injection
Frastim 300 Mg Injection Product Specifications
- Injection
- Colony Stimulating Factor (G-CSF, not a classic enzyme but a hematopoietic growth factor)
- Store between 2C to 8C. Do not freeze. Protect from light.
- Used as an adjunct therapy for managing neutropenia in cancer patients, bone marrow disorders, and in peripheral blood progenitor cell collection.
- 24 months from manufacturing date if stored properly.
- Sterile, preservative-free, ready-to-use prefilled syringe
- Filgrastim, excipients (such as sorbitol, sodium acetate, polysorbate 80, water for injection)
- Filgrastim 300 mcg
- To reduce the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing chemotherapy for malignancy, and in patients undergoing bone marrow transplantation; also used to increase neutrophil counts in patients with severe chronic neutropenia.
- Not applicable (recombinant product from bacterial fermentation)
- Clear, colorless solution
- Odorless (final pharmaceutical form)
- Approximately 4.0-4.5
- Stimulates granulocyte production; does not have catalytic (enzymatic) activity in the classic sense.
- Prescription only
- Should not be diluted with saline; only use 5% dextrose for dilution if necessary
- Known hypersensitivity to filgrastim or any component of the formulation
- 1 prefilled syringe of 1.0 ml
- Monitor for signs of splenic enlargement or rupture, allergic reaction, or adult respiratory distress syndrome
- Subcutaneous or intravenous injection
Product Description
Discover Frastim 300 Mg Injection - a rare and limited stock solution designed for unparalleled efficacy in reducing the duration of neutropenia. This dominant, new addition to hematopoietic care is presented as a decorated prefilled syringe (1.0 ml), ideal for subcutaneous or intravenous administration. Frastim harnesses the power of filgrastim (G-CSF) to stimulate granulocyte production, supporting patients during chemotherapy, bone marrow transplantation, or severe chronic neutropenia therapy. The sterile, preservative-free, colorless solution ensures safety and ease of use. For safe results, store between 2C and 8C. Prescription only.
Superior Features and Key Advantages
Frastim 300 Mg Injection arrives in a sterile, ready-to-use prefilled syringe, highlighting its superior material quality and unmatched convenience. The main advantage lies in its ability to significantly reduce infections by boosting neutrophil production. Competitive benefits include consistent dosing and a rare formulation that is both preservative-free and highly stable. This dominant choice ensures patient safety through rigorous quality controls, making it a trusted therapeutic partner for managing neutropenia in oncology and hematology settings.
Domestic and Export Market, Certifications
Frastim 300 Mg Injection has a strong presence in India's domestic mar, with favorable rates and timely delivered shipments to clinics and retailers nationwide. The main export markets include Southeast Asia, the Middle East, and Africa, where it's recognized for reliability. Each batch is produced under stringent certifications, ensuring global regulatory compliance and product authenticity. These certifications further enhance market trust, consolidating Frastim's reputation among importers and healthcare professionals alike.
Superior Features and Key Advantages
Frastim 300 Mg Injection arrives in a sterile, ready-to-use prefilled syringe, highlighting its superior material quality and unmatched convenience. The main advantage lies in its ability to significantly reduce infections by boosting neutrophil production. Competitive benefits include consistent dosing and a rare formulation that is both preservative-free and highly stable. This dominant choice ensures patient safety through rigorous quality controls, making it a trusted therapeutic partner for managing neutropenia in oncology and hematology settings.
Domestic and Export Market, Certifications
Frastim 300 Mg Injection has a strong presence in India's domestic mar, with favorable rates and timely delivered shipments to clinics and retailers nationwide. The main export markets include Southeast Asia, the Middle East, and Africa, where it's recognized for reliability. Each batch is produced under stringent certifications, ensuring global regulatory compliance and product authenticity. These certifications further enhance market trust, consolidating Frastim's reputation among importers and healthcare professionals alike.
FAQ's of Frastim 300 Mg Injection:
Q: How should Frastim 300 Mg Injection be stored to maintain its shelf life?
A: Frastim 300 Mg Injection must be stored between 2C to 8C, protected from light, and should not be frozen. Proper storage ensures its 24-month shelf life remains valid from the manufacturing date.Q: What makes Frastim 300 Mg Injection an unparalleled option for neutropenia management?
A: Frastim contains filgrastim, a dominant G-CSF formulation, designed for rapid stimulation of granulocyte production, thereby reducing neutropenia duration and infection rates during chemotherapy and bone marrow disorders.Q: When is Frastim 300 Mg Injection typically administered?
A: Frastim 300 Mg Injection is used during or after chemotherapy, following bone marrow transplantation, or in chronic neutropenia cases as prescribed by a healthcare professional.Q: Where can Frastim 300 Mg Injection be sourced in India or abroad?
A: Frastim is available through licensed dealers, distributors, exporters, importers, manufacturers, retailers, suppliers, traders, and wholesalers both across India and select export markets.Q: What precautions should be observed during usage of Frastim 300 Mg Injection?
A: Patients should be closely monitored for signs of splenic enlargement, allergic reactions, or adult respiratory distress syndrome. Do not administer if there is known hypersensitivity to filgrastim or its components.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Injection' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
